SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.
If you suffered losses exceeding $100,000 in Merck between February 3, 2022 and February 3, 2025 and would like to discuss ...
NEW YORK, NY / ACCESS Newswire / March 19, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE:MRK) between February 3, 2022 and ...
Merck KGa A officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the ...
Star Wars finally returns to the big screen with next year's The Mandalorian and Grogu, and Lucasfilm has now unveiled the ...
A panel of CDC advisers, who had originally been set to meet in February, will discuss the current measles outbreak as well ...
Shares of Merck & Co. Inc. MRK rallied 1.10% to $94.79 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.64% to 5,675. ...
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...
The change happens as ABC News celebrates the “Nightline” 45th anniversary on March 24 (12:35 a.m. ET) with a special episode, featuring all-new interviews with original anchor Ted Koppel, as well as ...
The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...
K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.
Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results